Open access · CC-BY
via OpenAlex
Defining a metabolic landscape of tumours: genome meets metabolism
Chandan Seth Nanda, Sharavan V. Venkateswaran, Neill Patani, Mariia Yuneva
British Journal of Cancer · 2019 · ▲ 96 citations
Abstract
Cancer is a complex disease of multiple alterations occuring at the epigenomic, genomic, transcriptomic, proteomic and/or metabolic levels. The contribution of genetic mutations in cancer initiation, progression and evolution is well understood. However, although metabolic changes in cancer have long been acknowledged and considered a plausible therapeutic target, the crosstalk between genetic and metabolic alterations throughout cancer types is not clearly defined. In this review, we summarise the present understanding of the interactions between genetic drivers of cellular transformation and cancer-associated metabolic changes, and how these interactions contribute to metabolic heterogeneity of tumours. We discuss the essential question of whether changes in metabolism are a cause or a consequence in the formation of cancer. We highlight two modes of how metabolism contributes to tumour formation. One is when metabolic reprogramming occurs downstream of oncogenic mutations in signalling pathways and supports tumorigenesis. The other is where metabolic reprogramming initiates transformation being either downstream of mutations in oncometabolite genes or induced by chronic wounding, inflammation, oxygen stress or metabolic diseases. Finally, we focus on the factors that can contribute to metabolic heterogeneity in tumours, including genetic heterogeneity, immunomodulatory factors and tissue architecture. We believe that an in-depth understanding of cancer metabolic reprogramming, and the role of metabolic dysregulation in tumour initiation and progression, can help identify cellular vulnerabilities that can be exploited for therapeutic use.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1038/s41416-019-0663-7
- Canonical
- link ↗
- Fetched
- 2026-06-05 MST
Cite this
APA
Nanda, C.S., Venkateswaran, S.V., Patani, N., & Yuneva, M. (2019). Defining a metabolic landscape of tumours: genome meets metabolism. <em>British Journal of Cancer</em>. https://doi.org/10.1038/s41416-019-0663-7
Vancouver
Nanda CS, Venkateswaran SV, Patani N, Yuneva M. Defining a metabolic landscape of tumours: genome meets metabolism. British Journal of Cancer. 2019. doi:10.1038/s41416-019-0663-7.
BibTeX
@article{chandan2019Defini,
title = {Defining a metabolic landscape of tumours: genome meets metabolism},
author = {Chandan Seth Nanda and Sharavan V. Venkateswaran and Neill Patani and Mariia Yuneva},
journal = {British Journal of Cancer},
year = {2019},
doi = {10.1038/s41416-019-0663-7},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Aging cell 2026
Open access · OA
Tissue-Level Transcriptomic Entropy Reveals Organ-Specific Aging Patterns and Predicts Cancer Progression.
Frontiers in bioscience 2020
Preprint · CC-BY
Epigenetic alterations in cancer
Frontiers in Physiology 2021
Open access · CC-BY
Metabolic Influences of Gut Microbiota Dysbiosis on Inflammatory Bowel Disease
Molecular Oncology 2007
Open access · OA
Genetic and epigenetic alterations as biomarkers for cancer detection, diagnosis and prognosis
Immunology and Cell Biology 2012
Open access · OA
The interplay between endoplasmic reticulum stress and inflammation
MedComm – Oncology 2025
Open access · CC-BY